Unpopular Choices Ahead For Pharma As France Wrestles With Spending Bill

 
• By Francesca Bruce
  
A French bill on social security spending for 2026 is likely to have a big impact on pharma. (Shutterstock)

More from Market Access

More from Health Technology Assessment